Table 1

Patient characteristics and tumour measurements

Number of cases (%)*
Entire patient poolCarboplatin-pemetrexedCisplatin-pemetrexed
Total cases22 (100)14 (100)8 (100)
Sex
 Male21 (95)14 (100)7 (88)
 Female1 (5)0 (0)1 (13)
Race
 Caucasian17 (77)11 (79)6 (75)
 African-American2 (9)0 (0)2 (25)
 Unspecified3 (14)3 (21)0 (0)
Histology
 Sarcomatoid type2 (9)2 (14)0 (0)
 Epithelioid type16 (73)11 (79)5 (63)
 Mixed type4 (18)1 (7)3 (38)
Age at diagnosis (years)
 Median65  68.5  58.5
 Range  47–80  49–80  47–75
Performance status
 011 (50)9 (41)2 (9)
 18 (36)3 (14)5 (23)
 23 (14)2 (9)1 (5)
Vital status at time of study
 Alive13 (59)9 (64)4 (50)
 Deceased9 (41)5 (36)4 (50)
Pleural thickness
Percentage change
 Mean−20−25−11
 Median−19−18−19
  • *Due to rounding, percentages may not sum to 100.